Wendy. W. Harrison
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Wendy. W. Harrison has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
Anthony J. Adams
University of California Berkeley School of Optometry and Group in Vision Science Berkeley California
2 shared publications- Jennyffer D. Smith
University of Houston College of Optometry, Houston, USA
2 shared publications Marilyn E. Schneck
University of California Berkeley School of Optometry and Group in Vision Science Berkeley California
2 shared publicationsShirin Barez
University of California Berkeley School of Optometry and Group in Vision Science Berkeley California
2 shared publicationsVladimir Yevseyenkov
Midwestern University Arizona College of Optometry Glendale Arizona USA
2 shared publicationsAllison Jussel Zagst
Department of Clinical Sciences, University of Houston College of Optometry, Houston, USA
1 shared publication
Latest Publications
- Open Access
- 1 December 2025
- Published by MDPI AG in Diabetology
- Vol. 6 (12) , 147
Exploring the Relationship Between Health Biomarkers and Performance on a Novel Color Perimetry Device in Prediabetes and Type 2 Diabetes
Background/Objectives: Type 2 diabetes (T2DM) is a leading cause of vision loss. Functional measurements (color vision and contrast sensitivity) are sensitive to early changes in eyes even before retinopathy is present. This study evaluates a novel color perimetry device as an indicator of diabetic eye disease. Methods: 40 (age-matched) subjects were divided into three groups by HbA1c or previous diagnosis (control ≤ 5.6%, prediabetes 5.7–6.4%, and diabetes ≥ 6.5%). Additional health metrics gathered included BMI, body fat %, total cholesterol, HDL/LDL levels, blood glucose, and blood pressure. Novel color perimetry which measures chromatic thresholds at four locations, three degrees from the fovea, for five colors (achromatic, red, green, blue, and yellow) was completed. Mars contrast and L’Anthony D15 color testing were also completed. Lens photos excluded those with cataracts. Results: There were differences between the groups for HbA1c (p < 0.001), BMI (p = 0.046), body fat % (p = 0.020), and color perimetry for the yellow condition only (p = 0.013). The achromatic condition was highly associated with Mars contrast sensitivity (p < 0.001). HbA1c was associated with both parvocellular (average of red and green) (p = 0.014) and koniocellular (average of blue and yellow) color perimetry performance (p = 0.022). Conclusions: HbA1c is associated with color perimetry across both retinal pathways. The yellow condition in particular holds promise as a biomarker for the presence of functional changes in diabetes prior to the onset of retinopathy. Other health metrics did not influence chromatic thresholds. More research needs to be conducted to evaluate color perimetry in these patient groups to understand these relationships.
- 1 December 2025
- Published by MDPI AG in Diabetology
- Vol. 6 (12) , 147
Open AccessExploring the Relationship Between Health Biomarkers and Performance on a Novel Color Perimetry Device in Prediabetes and Type 2 Diabetes
Background/Objectives: Type 2 diabetes (T2DM) is a leading cause of vision loss. Functional measurements (color vision and contrast sensitivity) are sensitive to early changes in eyes even before retinopathy is present. This study evaluates a novel color perimetry device as an indicator of diabetic eye disease. Methods: 40 (age-matched) subjects were divided into three groups by HbA1c or previous diagnosis (control ≤ 5.6%, prediabetes 5.7–6.4%, and diabetes ≥ 6.5%). Additional health metrics gathered included BMI, body fat %, total cholesterol, HDL/LDL levels, blood glucose, and blood pressure. Novel color perimetry which measures chromatic thresholds at four locations, three degrees from the fovea, for five colors (achromatic, red, green, blue, and yellow) was completed. Mars contrast and L’Anthony D15 color testing were also completed. Lens photos excluded those with cataracts. Results: There were differences between the groups for HbA1c (p < 0.001), BMI (p = 0.046), body fat % (p = 0.020), and color perimetry for the yellow condition only (p = 0.013). The achromatic condition was highly associated with Mars contrast sensitivity (p < 0.001). HbA1c was associated with both parvocellular (average of red and green) (p = 0.014) and koniocellular (average of blue and yellow) color perimetry performance (p = 0.022). Conclusions: HbA1c is associated with color perimetry across both retinal pathways. The yellow condition in particular holds promise as a biomarker for the presence of functional changes in diabetes prior to the onset of retinopathy. Other health metrics did not influence chromatic thresholds. More research needs to be conducted to evaluate color perimetry in these patient groups to understand these relationships.
- 5 August 2025
- Published by Wiley in Optometry and Vision Science
- Vol. 102 (9) , 578-585
Repeatability of a novel chromatic perimeter in a cohort of people with and without glucose dysfunction
SIGNIFICANCE: Sensitive diagnostic techniques are crucial for the early detection of diabetes. Here, we tested a novel color perimeter and found it repeatable in control subjects. It also has the potential to detect functional changes in diabetic eye disease. PURPOSE: Type 2 diabetes (T2DM) causes retinal dysfunction before the appearance of retinopathy. Our group developed a color perimeter that measures chromatic sensitivity at discrete retinal locations. This study evaluates the repeatability of this perimeter in detecting chromatic sensitivity changes in normal and glucose‐dysfunctional states. METHODS: Eighteen subjects, 49.4 (7.8) years, nine controls (HbA1c ≤5.6%), nine with glucose dysfunction (HbA1c ≥5.7%, no/mild retinopathy), participated. Congenital color defects, diseases affecting color vision, vision >20/32, and those with tinted glasses were excluded. Visual acuity, L’Anthony D‐15, and color perimetry were performed at two visits within 9 months. Lens and fundus photographs were taken. Chromatic thresholds were measured at four diagonal locations 3° from fixation in the right eye using 0.5° diameter red, green, blue, and yellow stimuli through a randomly interleaved staircase method. Thresholds were converted to log cone contrast and averaged. The test–retest repeatabilities were analyzed using Bland‐Altman plots. Trends were analyzed using linear regression, and Wilcoxon matched‐pairs signed rank test and t tests for comparisons. RESULTS: Clinical tests did not differ between visits (all p ≥ 0.05). Bland‐Altman control group plots showed bias lines and measurement differences near zero for all colors (all p > 0.53). Trend lines were horizontal and near zero for all colors (all p > 0.22). In the glucose dysfunction group, the mean of measurement differences was not significantly different from zero for all colors (all p > 0.13). However, green, blue, and yellow stimuli had significant or trending negative‐sloped trend lines (p = 0.03, 0.04, and 0.06, respectively). Detailed review of individual clinical data revealed that subjects with relatively longer duration of T2DM, higher HbA1c, and/or mild retinopathy often performed worse on their second visit. CONCLUSIONS: The novel color perimeter demonstrated both good repeatability and potential for detecting subtle visual changes due to glucose dysfunction. Further testing is necessary to compare performance with other structural and functional tests.
- 5 August 2025
- Published by Wiley in Optometry and Vision Science
- Vol. 102 (9) , 578-585
Repeatability of a novel chromatic perimeter in a cohort of people with and without glucose dysfunction
SIGNIFICANCE: Sensitive diagnostic techniques are crucial for the early detection of diabetes. Here, we tested a novel color perimeter and found it repeatable in control subjects. It also has the potential to detect functional changes in diabetic eye disease. PURPOSE: Type 2 diabetes (T2DM) causes retinal dysfunction before the appearance of retinopathy. Our group developed a color perimeter that measures chromatic sensitivity at discrete retinal locations. This study evaluates the repeatability of this perimeter in detecting chromatic sensitivity changes in normal and glucose‐dysfunctional states. METHODS: Eighteen subjects, 49.4 (7.8) years, nine controls (HbA1c ≤5.6%), nine with glucose dysfunction (HbA1c ≥5.7%, no/mild retinopathy), participated. Congenital color defects, diseases affecting color vision, vision >20/32, and those with tinted glasses were excluded. Visual acuity, L’Anthony D‐15, and color perimetry were performed at two visits within 9 months. Lens and fundus photographs were taken. Chromatic thresholds were measured at four diagonal locations 3° from fixation in the right eye using 0.5° diameter red, green, blue, and yellow stimuli through a randomly interleaved staircase method. Thresholds were converted to log cone contrast and averaged. The test–retest repeatabilities were analyzed using Bland‐Altman plots. Trends were analyzed using linear regression, and Wilcoxon matched‐pairs signed rank test and t tests for comparisons. RESULTS: Clinical tests did not differ between visits (all p ≥ 0.05). Bland‐Altman control group plots showed bias lines and measurement differences near zero for all colors (all p > 0.53). Trend lines were horizontal and near zero for all colors (all p > 0.22). In the glucose dysfunction group, the mean of measurement differences was not significantly different from zero for all colors (all p > 0.13). However, green, blue, and yellow stimuli had significant or trending negative‐sloped trend lines (p = 0.03, 0.04, and 0.06, respectively). Detailed review of individual clinical data revealed that subjects with relatively longer duration of T2DM, higher HbA1c, and/or mild retinopathy often performed worse on their second visit. CONCLUSIONS: The novel color perimeter demonstrated both good repeatability and potential for detecting subtle visual changes due to glucose dysfunction. Further testing is necessary to compare performance with other structural and functional tests.
- Open Access
Alterations in Tear Proteomes of Adults with Pre-Diabetes and Type 2 Diabetes Mellitus but Without Diabetic Retinopathy
Background: Type 2 diabetes mellitus (T2DM) is an epidemic chronic disease that affects millions of people worldwide. This study aims to explore the impact of T2DM on the tear proteome, specifically investigating whether alterations occur before the development of diabetic retinopathy. Methods: Flush tear samples were collected from healthy subjects and subjects with preDM and T2DM. Tear proteins were processed and analyzed by mass spectrometry-based shotgun proteomics using a data-independent acquisition parallel acquisition serial fragmentation (diaPASEF) approach. Machine learning algorithms, including random forest, lasso regression, and support vector machine, and statistical tools were used to identify potential biomarkers. Results: Machine learning models identified 17 proteins with high importance in classification. Among these, five proteins (cystatin-S, S100-A11, submaxillary gland androgen-regulated protein 3B, immunoglobulin lambda variable 3–25, and lambda constant 3) exhibited differential abundance across these three groups. No correlations were identified between proteins and clinical assessments of the ocular surface. Notably, the 17 important proteins showed superior prediction accuracy in distinguishing all three groups (healthy, preDM, and T2DM) compared to the five proteins that were statistically significant. Conclusions: Alterations in the tear proteome profile were observed in adults with preDM and T2DM before the clinical diagnosis of ocular abnormality, including retinopathy.
Open AccessAlterations in Tear Proteomes of Adults with Pre-Diabetes and Type 2 Diabetes Mellitus but Without Diabetic Retinopathy
Background: Type 2 diabetes mellitus (T2DM) is an epidemic chronic disease that affects millions of people worldwide. This study aims to explore the impact of T2DM on the tear proteome, specifically investigating whether alterations occur before the development of diabetic retinopathy. Methods: Flush tear samples were collected from healthy subjects and subjects with preDM and T2DM. Tear proteins were processed and analyzed by mass spectrometry-based shotgun proteomics using a data-independent acquisition parallel acquisition serial fragmentation (diaPASEF) approach. Machine learning algorithms, including random forest, lasso regression, and support vector machine, and statistical tools were used to identify potential biomarkers. Results: Machine learning models identified 17 proteins with high importance in classification. Among these, five proteins (cystatin-S, S100-A11, submaxillary gland androgen-regulated protein 3B, immunoglobulin lambda variable 3–25, and lambda constant 3) exhibited differential abundance across these three groups. No correlations were identified between proteins and clinical assessments of the ocular surface. Notably, the 17 important proteins showed superior prediction accuracy in distinguishing all three groups (healthy, preDM, and T2DM) compared to the five proteins that were statistically significant. Conclusions: Alterations in the tear proteome profile were observed in adults with preDM and T2DM before the clinical diagnosis of ocular abnormality, including retinopathy.
- Open Access
- 1 July 2024
- Published by Taylor & Francis in Clinical Optometry
- Vol. ume 16, 147-155
Variations in Retinal Oxygen Saturation in a Diverse Healthy Population
Purpose: Local retinal oxygen saturation is a research technique, which has the potential as a biomarker for diabetes. However, normative data has not been established. This study examined differences in oxygen saturation around the macula and characterizes the relationship between age, race, refractive error (RE), sex, blood pressure (BP), prediabetic status and oxygen saturation. Methods: Fifty-nine subjects aged 22– 69 (38.8 ± 14.7 years) were included who were racially diverse and with equal gender distribution. None had eye disease. Oxygen saturation was taken with the Zilia Ocular in 4 locations around the macula 3.1 degrees from the fovea and they were also averaged. BP, RE, and HbA1c were noted. Regression analyses for oximetry and other factors were completed as were t-tests with multiple comparison corrections. Results: There were significant variations in oximetry measures by race, with higher pigmentation levels associated with lower oximetry values (p < 0.01). There was no relationship between oximetry and sex (p = 0.34), RE (p = 0.67), BP (systolic p = 0.61, diastolic p = 0.71) nor prediabetic status (p = 0.87). Oximetry was associated with age when controlling for race (P < 0.002). Nasal-temporal variations showed nasal oximetry to higher than temporal measures (P < 0.01). Conclusion: This study revealed race/pigmentation is an important influence on oximetry measures. Retinal location also caused variations, likely due to proximity to larger vessels nasally. No differences in sex, RE nor BP were observed to alter local oxygen saturation. However, age was correlated when considered with race. This study will inform our future work in different disease states and is an important first step in evaluating this technology. Plain Language Summary: This study evaluates a new research instrument (Zilia Ocular) which measures how much oxygen is in the very small blood vessels of the retina. Our group wanted to evaluate healthy people to find out if the measurements the instrument takes are different in different sexes, ages, races, glasses prescriptions and blood pressures. We also looked at if they were changed in people with prediabetes and if it is different in different locations on the retina. We found that the measures are different in different races and ages. The measures also change with location in the eye. The other factors did not change the measurements of oxygen saturation on this instrument. We need to know this information because we want to detect changes in the retina in diabetes in diverse patient groups; however, we need to know about normal variations to better understand and collect that data.
- 1 July 2024
- Published by Taylor & Francis in Clinical Optometry
- Vol. ume 16, 147-155
Open AccessVariations in Retinal Oxygen Saturation in a Diverse Healthy Population
Purpose: Local retinal oxygen saturation is a research technique, which has the potential as a biomarker for diabetes. However, normative data has not been established. This study examined differences in oxygen saturation around the macula and characterizes the relationship between age, race, refractive error (RE), sex, blood pressure (BP), prediabetic status and oxygen saturation. Methods: Fifty-nine subjects aged 22– 69 (38.8 ± 14.7 years) were included who were racially diverse and with equal gender distribution. None had eye disease. Oxygen saturation was taken with the Zilia Ocular in 4 locations around the macula 3.1 degrees from the fovea and they were also averaged. BP, RE, and HbA1c were noted. Regression analyses for oximetry and other factors were completed as were t-tests with multiple comparison corrections. Results: There were significant variations in oximetry measures by race, with higher pigmentation levels associated with lower oximetry values (p < 0.01). There was no relationship between oximetry and sex (p = 0.34), RE (p = 0.67), BP (systolic p = 0.61, diastolic p = 0.71) nor prediabetic status (p = 0.87). Oximetry was associated with age when controlling for race (P < 0.002). Nasal-temporal variations showed nasal oximetry to higher than temporal measures (P < 0.01). Conclusion: This study revealed race/pigmentation is an important influence on oximetry measures. Retinal location also caused variations, likely due to proximity to larger vessels nasally. No differences in sex, RE nor BP were observed to alter local oxygen saturation. However, age was correlated when considered with race. This study will inform our future work in different disease states and is an important first step in evaluating this technology. Plain Language Summary: This study evaluates a new research instrument (Zilia Ocular) which measures how much oxygen is in the very small blood vessels of the retina. Our group wanted to evaluate healthy people to find out if the measurements the instrument takes are different in different sexes, ages, races, glasses prescriptions and blood pressures. We also looked at if they were changed in people with prediabetes and if it is different in different locations on the retina. We found that the measures are different in different races and ages. The measures also change with location in the eye. The other factors did not change the measurements of oxygen saturation on this instrument. We need to know this information because we want to detect changes in the retina in diabetes in diverse patient groups; however, we need to know about normal variations to better understand and collect that data.
- 26 July 2023
- Published by Springer Nature in Documenta Ophthalmologica
- Vol. 147 (2) , 99-107
Foveal avascular zone size and mfERG metrics in diabetes and prediabetes: a pilot study of the relationship between structure and function
- 26 July 2023
- Published by Springer Nature in Documenta Ophthalmologica
- Vol. 147 (2) , 99-107
Foveal avascular zone size and mfERG metrics in diabetes and prediabetes: a pilot study of the relationship between structure and function
- Open Access
- 11 June 2023
- Published by Elsevier in Diabetes Epidemiology and Management
- Vol. 12
Evaluation of retinal structure and function in prediabetes
- 11 June 2023
- Published by Elsevier in Diabetes Epidemiology and Management
- Vol. 12
Open AccessEvaluation of retinal structure and function in prediabetes
- 21 September 2020
- Published by Springer Nature in Ophthalmic and Physiological Optics
- Vol. 40 (6) , 770-777
Functional retinal outcomes in patients with prediabetes and type 2 diabetes
Purpose: Type 2 diabetes (T2DM) is a leading cause of visual impairment. Its precursor, prediabetes (preDM), is growing in numbers every year. While it is well known that T2DM causes changes in retinal function early in the disease process, it is likely that some of these changes emerge during the preDM stage. This study evaluates retinal function measures in patients with preDM to determine if there are differences in colour vision, contrast sensitivity (CS), and multifocal electroretinogram (mfERG) measures present before T2DM is diagnosed. Methods: The L’Anthony desaturated D‐15 test, Mars Chart CS test, and mfERG were administered on the right eye of 43 participants; 15 controls (HbA1c 5.6%), 17 with preDM (HbA1c 5.7%–6.4%), and 11 with T2DM (either physician diagnosed or with untreated HbA1c ≥ 6.5%). HbA1c values were measured at the time of the other tests. Colour vision confusion scores (CVCS) were calculated from the D‐15 using the method developed by Torok. Multivariate regression (which controlled for age differences) was used to evaluate the relationship of HbA1c and functional measures. Kruskal‐Wallis tests were also used to evaluate differences between groups with post‐hoc analysis. Results: CVCSs were significantly different between the three groups ( p = 0.009). There was an association between higher CVCS and higher HbA1c values across all groups as well as specifically within the preDM group when controlling for age ( R 2 = 0.29, p = 0.01 and R 2 = 0.39, p = 0.02 respectively). Multivariate regression of all of the functional tests together and HbA1c found only colour vision remained significant, indicating that the functional examination metrics may provide redundant data, with similar changes in prediabetes where colour vision may be the strongest indicator early in the process. Conclusions: Patients with prediabetes have functional changes that can be measured in the retina before the diagnosis of diabetes, with the L’Anthony D‐15 colour vision test providing the strongest association with glucose dysregulation in this population. This has important implications for follow up and screening for diabetes within optometric practices. Further studies are needed to follow these patients over time to see how and when these metrics change.
- 21 September 2020
- Published by Springer Nature in Ophthalmic and Physiological Optics
- Vol. 40 (6) , 770-777
Functional retinal outcomes in patients with prediabetes and type 2 diabetes
Purpose: Type 2 diabetes (T2DM) is a leading cause of visual impairment. Its precursor, prediabetes (preDM), is growing in numbers every year. While it is well known that T2DM causes changes in retinal function early in the disease process, it is likely that some of these changes emerge during the preDM stage. This study evaluates retinal function measures in patients with preDM to determine if there are differences in colour vision, contrast sensitivity (CS), and multifocal electroretinogram (mfERG) measures present before T2DM is diagnosed. Methods: The L’Anthony desaturated D‐15 test, Mars Chart CS test, and mfERG were administered on the right eye of 43 participants; 15 controls (HbA1c 5.6%), 17 with preDM (HbA1c 5.7%–6.4%), and 11 with T2DM (either physician diagnosed or with untreated HbA1c ≥ 6.5%). HbA1c values were measured at the time of the other tests. Colour vision confusion scores (CVCS) were calculated from the D‐15 using the method developed by Torok. Multivariate regression (which controlled for age differences) was used to evaluate the relationship of HbA1c and functional measures. Kruskal‐Wallis tests were also used to evaluate differences between groups with post‐hoc analysis. Results: CVCSs were significantly different between the three groups ( p = 0.009). There was an association between higher CVCS and higher HbA1c values across all groups as well as specifically within the preDM group when controlling for age ( R 2 = 0.29, p = 0.01 and R 2 = 0.39, p = 0.02 respectively). Multivariate regression of all of the functional tests together and HbA1c found only colour vision remained significant, indicating that the functional examination metrics may provide redundant data, with similar changes in prediabetes where colour vision may be the strongest indicator early in the process. Conclusions: Patients with prediabetes have functional changes that can be measured in the retina before the diagnosis of diabetes, with the L’Anthony D‐15 colour vision test providing the strongest association with glucose dysregulation in this population. This has important implications for follow up and screening for diabetes within optometric practices. Further studies are needed to follow these patients over time to see how and when these metrics change.
- 1 August 2020
- Published by Wiley in Optometry and Vision Science
- Vol. 97 (8) , 555-560
Case Report: Long‐term Structural and Functional Effects of Ethambutol Optic Neuropathy
SIGNIFICANCE: This case report demonstrates reduction in the retinal nerve fiber layer (RNFL) thickness and an abnormal electroretinogram after toxic optic neuropathy from ethambutol, more than 1 year after improvements in visual acuity (VA) and visual fields (VFs) were seen. Although many studies have described complications of ethambutol, continuing reduction in RNFL thickness 2 years after discontinuation has not been described elsewhere. PURPOSE: It is well known that ethambutol can cause optic nerve toxicity, visual impairment, and VF loss. Visual acuity can be regained after stopping the drug; however, the amount and time frame are variable. There are few data on long‐term follow‐up of these cases to direct clinicians how to proceed once VA has stabilized. Here we present a case with 2 years of follow‐up for a patient with ethambutol toxicity, showing the condition change even after VA becomes normal. CASE REPORT: A 61‐year‐old man presented shortly after discontinuing ethambutol for Mycobacterium avium complex. Visual acuity values were 20/70 in the right eye and 20/125 in the left eye with cecocentral VF scotomas. Optical coherence tomography showed normal RNFL. Visual‐evoked potentials were significantly reduced and delayed. Over the course of 2 years, the patient became asymptomatic as VA and VF returned to normal and visual‐evoked potential improved. However, the optical coherence tomography RNFL was reduced from each visit to the next, and the electroretinogram showed decreased scotopic and photopic amplitudes. CONCLUSIONS: Signs of ethambutol toxicity may remain or worsen years after discontinuation, even in the absence of patient symptoms and with normal VA and VF.
- 1 August 2020
- Published by Wiley in Optometry and Vision Science
- Vol. 97 (8) , 555-560
Case Report: Long‐term Structural and Functional Effects of Ethambutol Optic Neuropathy
SIGNIFICANCE: This case report demonstrates reduction in the retinal nerve fiber layer (RNFL) thickness and an abnormal electroretinogram after toxic optic neuropathy from ethambutol, more than 1 year after improvements in visual acuity (VA) and visual fields (VFs) were seen. Although many studies have described complications of ethambutol, continuing reduction in RNFL thickness 2 years after discontinuation has not been described elsewhere. PURPOSE: It is well known that ethambutol can cause optic nerve toxicity, visual impairment, and VF loss. Visual acuity can be regained after stopping the drug; however, the amount and time frame are variable. There are few data on long‐term follow‐up of these cases to direct clinicians how to proceed once VA has stabilized. Here we present a case with 2 years of follow‐up for a patient with ethambutol toxicity, showing the condition change even after VA becomes normal. CASE REPORT: A 61‐year‐old man presented shortly after discontinuing ethambutol for Mycobacterium avium complex. Visual acuity values were 20/70 in the right eye and 20/125 in the left eye with cecocentral VF scotomas. Optical coherence tomography showed normal RNFL. Visual‐evoked potentials were significantly reduced and delayed. Over the course of 2 years, the patient became asymptomatic as VA and VF returned to normal and visual‐evoked potential improved. However, the optical coherence tomography RNFL was reduced from each visit to the next, and the electroretinogram showed decreased scotopic and photopic amplitudes. CONCLUSIONS: Signs of ethambutol toxicity may remain or worsen years after discontinuation, even in the absence of patient symptoms and with normal VA and VF.
- 10 October 2018
- Published by Springer Nature in Documenta Ophthalmologica
- Vol. 137 (3) , 143-149
Foveal amplitudes of multifocal electroretinograms are larger following full-field electroretinograms
The clinical standards for multifocal electroretinograms (mfERG) call for adaption to normal room lighting before the mfERG begins. They specify that any assessments where bright lights are used, should be done after the mfERG to prevent excess stimulation of retinal cells. However, full-field electroretinograms (FFERG) are performed prior to mfERGs in some clinical settings. It is unclear from the literature whether the FFERG has an impact on the mfERG. This study seeks to examine the effect of the FFERG on the mfERG when performed sequentially.
- 10 October 2018
- Published by Springer Nature in Documenta Ophthalmologica
- Vol. 137 (3) , 143-149
Foveal amplitudes of multifocal electroretinograms are larger following full-field electroretinograms
The clinical standards for multifocal electroretinograms (mfERG) call for adaption to normal room lighting before the mfERG begins. They specify that any assessments where bright lights are used, should be done after the mfERG to prevent excess stimulation of retinal cells. However, full-field electroretinograms (FFERG) are performed prior to mfERGs in some clinical settings. It is unclear from the literature whether the FFERG has an impact on the mfERG. This study seeks to examine the effect of the FFERG on the mfERG when performed sequentially.
- 27 June 2017
- Published by Springer Nature in Ophthalmic and Physiological Optics
- Vol. 37 (4) , 482-488
The corneal nerve density in the sub‐basal plexus decreases with increasing myopia: a pilot study
Purpose: Myopia can cause many changes in the health of the eye. As it becomes more prevalent worldwide, more patients seek correction in the form of glasses, contact lenses and refractive surgery. In this study we explore the impact that high myopia has on central corneal nerve density by comparing sub basal nerve plexus density measured by confocal microscopy in a variety of refractive errors. Methods: Seventy healthy adult subjects between the ages of 21–50 years participated in this study. The study took place in two phases with no overlapping subjects ( n = 30 phase 1 and n = 40 phase 2). In both phases an autorefraction, keratometry reading, corneal thickness measure and confocal corneal scan of the sub basal nerve plexus were performed for both eyes. There were 11 hyperopes (+0.50 to +3.50 DS ), six emmetropes (−0.25 to +0.50 DS ), 30 low myopes (−5.50 to −0.50 DS ), and 23 high myopes (−5.50 DS and above). In the second phase of the study additional tests were performed including an axial length, additional corneal scans, and a questionnaire that asked about age of first refractive correction and contact lens wear. Corneal nerves were imaged over the central cornea with a Nidek CS 4 confocal microscope (460 × 345 μm field). Nerves were evaluated using the NeuronJ program for density calculation. One eye was selected for inclusion based on image quality and higher refractive error (more myopic or hyperopic). Results: As myopia increased, nerve density decreased ( t 1 = 3.86, p < 0.001). We also note a decrease in data scatter above −7 D. The relationship between axial length values and nerve density was also significant and the slope was not as robust as refractive error ( t 1 = 2.4, p < 0.04). As expected there was a significant difference between the four groups in axial length ( F 3 = 19.9, p < 0.001) and age of first refractive correction of the myopic groups (14.9 vs 11.5 years; t 46 = 2.99 p < 0.01). There was no difference in keratometry readings or corneal thickness between the groups ( F 3 = 0.6, p = 0.66 and F 3 = 1.2, p = 0.33 respectively). Conclusion: Corneal nerve density in the sub‐basal plexus decreased with increasing myopia. This could have implications for corneal surgery and contact lens wear in this patient population.
- 27 June 2017
- Published by Springer Nature in Ophthalmic and Physiological Optics
- Vol. 37 (4) , 482-488
The corneal nerve density in the sub‐basal plexus decreases with increasing myopia: a pilot study
Purpose: Myopia can cause many changes in the health of the eye. As it becomes more prevalent worldwide, more patients seek correction in the form of glasses, contact lenses and refractive surgery. In this study we explore the impact that high myopia has on central corneal nerve density by comparing sub basal nerve plexus density measured by confocal microscopy in a variety of refractive errors. Methods: Seventy healthy adult subjects between the ages of 21–50 years participated in this study. The study took place in two phases with no overlapping subjects ( n = 30 phase 1 and n = 40 phase 2). In both phases an autorefraction, keratometry reading, corneal thickness measure and confocal corneal scan of the sub basal nerve plexus were performed for both eyes. There were 11 hyperopes (+0.50 to +3.50 DS ), six emmetropes (−0.25 to +0.50 DS ), 30 low myopes (−5.50 to −0.50 DS ), and 23 high myopes (−5.50 DS and above). In the second phase of the study additional tests were performed including an axial length, additional corneal scans, and a questionnaire that asked about age of first refractive correction and contact lens wear. Corneal nerves were imaged over the central cornea with a Nidek CS 4 confocal microscope (460 × 345 μm field). Nerves were evaluated using the NeuronJ program for density calculation. One eye was selected for inclusion based on image quality and higher refractive error (more myopic or hyperopic). Results: As myopia increased, nerve density decreased ( t 1 = 3.86, p < 0.001). We also note a decrease in data scatter above −7 D. The relationship between axial length values and nerve density was also significant and the slope was not as robust as refractive error ( t 1 = 2.4, p < 0.04). As expected there was a significant difference between the four groups in axial length ( F 3 = 19.9, p < 0.001) and age of first refractive correction of the myopic groups (14.9 vs 11.5 years; t 46 = 2.99 p < 0.01). There was no difference in keratometry readings or corneal thickness between the groups ( F 3 = 0.6, p = 0.66 and F 3 = 1.2, p = 0.33 respectively). Conclusion: Corneal nerve density in the sub‐basal plexus decreased with increasing myopia. This could have implications for corneal surgery and contact lens wear in this patient population.